← Back to Discover
Omega Fund Management, LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $185,685,956
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- Bicara Therapeutics Inc. · Common Stock · 055477103 · shares: $54,099,634
- Nuvation Bio Inc. · Common Stock Class A · 67080N101 · shares: $45,900,586
- Kestra Med Technologies Ltd · Common Stock · G52441105 · shares: $26,003,471
- BridgeBio Oncology Therapeutics Inc. · Common Stock · 107924102 · shares: $25,067,217
- Beta Bionics Inc. · Common Stock · 08659B102 · shares: $20,624,588
- Alumis Inc. · Common Stock · 022307102 · shares: $6,788,916
- Sana Biotechnology, Inc. · Common Stock · 799566104 · shares: $2,944,688
- ImageneBio, Inc. · Common Stock · 45175G207 · shares: $2,686,630
- enGene Holdings Inc. · Common Stock · 29286M105 · shares: $1,516,098
- Odyssey Therapeutics Inc. · Common Stock · 67613T104 · shares: $54,128
Reported holdings
10 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| Bicara Therapeutics Inc. | Common Stock | 055477103 | — | 1,822,150 shares | $54,099,634 |
| Nuvation Bio Inc. | Common Stock Class A | 67080N101 | — | 8,081,089 shares | $45,900,586 |
| Kestra Med Technologies Ltd | Common Stock | G52441105 | — | 1,022,149 shares | $26,003,471 |
| BridgeBio Oncology Therapeutics Inc. | Common Stock | 107924102 | — | 3,289,661 shares | $25,067,217 |
| Beta Bionics Inc. | Common Stock | 08659B102 | — | 1,316,183 shares | $20,624,588 |
| Alumis Inc. | Common Stock | 022307102 | — | 241,255 shares | $6,788,916 |
| Sana Biotechnology, Inc. | Common Stock | 799566104 | — | 843,750 shares | $2,944,688 |
| ImageneBio, Inc. | Common Stock | 45175G207 | — | 455,361 shares | $2,686,630 |
| enGene Holdings Inc. | Common Stock | 29286M105 | — | 876,357 shares | $1,516,098 |
| Odyssey Therapeutics Inc. | Common Stock | 67613T104 | — | 2,893 shares | $54,128 |